Current and historical daily PE Ratio for Bio-Techne Corp (
) from 2020 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Bio-Techne stock (BSP:T1CH34) PE ratio as of Apr 26 2024 is 45.41.
More Details
Bio-Techne Corp (BSP:T1CH34) PE Ratio (TTM) Chart
Bio-Techne Corp (BSP:T1CH34) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 921
- 1
- 2
- 3
- 4
- 5
- 6
- 11
| Bio-Techne PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-27 | 47.6 | 2024-02-22 | 50.2 |
| 2024-04-25 | 47.6 | 2024-02-21 | 50.2 |
| 2024-04-24 | 47.6 | 2024-02-20 | 50.2 |
| 2024-04-23 | 47.6 | 2024-02-19 | 48.6 |
| 2024-04-22 | 47.0 | 2024-02-16 | 48.6 |
| 2024-04-19 | 49.8 | 2024-02-15 | 48.6 |
| 2024-04-18 | 49.8 | 2024-02-14 | 48.6 |
| 2024-04-17 | 49.8 | 2024-02-12 | 48.6 |
| 2024-04-16 | 49.8 | 2024-02-09 | 48.6 |
| 2024-04-15 | 49.8 | 2024-02-08 | 48.6 |
| 2024-04-12 | 49.8 | 2024-02-07 | 48.6 |
| 2024-04-11 | 49.8 | 2024-02-06 | 47.8 |
| 2024-04-10 | 49.8 | 2024-02-05 | 47.8 |
| 2024-04-09 | 49.8 | 2024-02-02 | 47.8 |
| 2024-04-08 | 49.8 | 2024-02-01 | 47.8 |
| 2024-04-05 | 49.8 | 2024-01-31 | 49.9 |
| 2024-04-04 | 49.7 | 2024-01-30 | 49.9 |
| 2024-04-03 | 50.0 | 2024-01-29 | 49.9 |
| 2024-04-02 | 50.1 | 2024-01-26 | 49.9 |
| 2024-04-01 | 50.8 | 2024-01-25 | 49.9 |
| 2024-03-28 | 50.0 | 2024-01-24 | 49.9 |
| 2024-03-27 | 50.0 | 2024-01-23 | 49.9 |
| 2024-03-26 | 49.6 | 2024-01-22 | 49.9 |
| 2024-03-25 | 50.0 | 2024-01-19 | 49.9 |
| 2024-03-22 | 52.0 | 2024-01-18 | 50.7 |
| 2024-03-21 | 51.4 | 2024-01-17 | 50.7 |
| 2024-03-20 | 51.4 | 2024-01-16 | 50.7 |
| 2024-03-19 | 43.6 | 2024-01-15 | 51.4 |
| 2024-03-18 | 21.8 | 2024-01-12 | 51.8 |
| 2024-03-15 | 53.1 | 2024-01-11 | 51.8 |
| 2024-03-14 | 53.1 | 2024-01-10 | 52.1 |
| 2024-03-13 | 53.1 | 2024-01-09 | 52.1 |
| 2024-03-12 | 53.1 | 2024-01-08 | 50.6 |
| 2024-03-11 | 54.2 | 2024-01-05 | 51.2 |
| 2024-03-08 | 50.9 | 2024-01-04 | 51.1 |
| 2024-03-07 | 50.9 | 2024-01-03 | 42.3 |
| 2024-03-06 | 54.4 | 2024-01-02 | 42.3 |
| 2024-03-05 | 52.9 | 2024-01-01 | 42.3 |
| 2024-03-04 | 53.3 | 2023-12-29 | 42.3 |
| 2024-03-01 | 53.3 | 2023-12-28 | 42.3 |
| 2024-02-29 | 53.3 | 2023-12-27 | 38.0 |
| 2024-02-28 | 53.3 | 2023-12-26 | 38.0 |
| 2024-02-27 | 52.2 | 2023-12-25 | 38.0 |
| 2024-02-26 | 51.6 | 2023-12-22 | 38.0 |
| 2024-02-23 | 50.2 | 2023-12-21 | 38.0 |
Bio-Techne Corp (BSP:T1CH34) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Bio-Techne Corp
NAICS : 325414
SIC : 2836
ISIN : BRT1CHBDR003
Share Class Description:
BSP:T1CH34: BRDRCompare
Compare
Traded in other countries / regions
TECH.USAT1CH34.BrazilTE1.GermanyTECH.Mexico IPO Date
2020-10-13Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers